Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach

Reverse transcriptase inhibitors (RTIs) are currently broadly prescribed for the treatment of HIV infection but are also thought to prevent Alzheimer’s Disease (AD) progression by protecting against amyloidosis. Our study evaluates the hypothesis that reverse transcriptase inhibitors protect against...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Ronald J., Pal, Shibangi, Achim, Cristian L., Sundermann, Erin, Moore, David J., Soontornniyomkij, Virawudh, Feldman, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312930/
https://www.ncbi.nlm.nih.gov/pubmed/37398361
http://dx.doi.org/10.21203/rs.3.rs-3040756/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312930/
https://www.ncbi.nlm.nih.gov/pubmed/37398361
http://dx.doi.org/10.21203/rs.3.rs-3040756/v1

Ejemplares similares